Welcome. MP Healthcare Venture Management (MPH)
is a Boston-based lifesciences venture capital firm passionate about connecting ideas, technologies, and business processes to create tomorrow’s healthcare innovations. Find out how connecting with MPH can get your ideas to market faster and bring value to your vision. More

News and Events

13 February 2017

miRagen Therapeutics Completes Merger with Signal Genetics and Concurrent $40.7 Million Equity Financing More

3 November 2016

miRagen Therapeutics Announces Presentation of MRG-106 Clinical Data at American Society of Hematology Annual Meeting More

31 October 2016

miRagen Therapeutics and Signal Genetics Sign Merger AgreementMore

9 September 2016

miRagen Therapeutics Appoints Kevin Koch, Ph.D., to Its Board of Directors.More




Featured Portfolio